Aralez Bio Overview
- Year Founded
-
2019

- Status
-
Private
- Employees
-
22

- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$10M
- Investors
-
10
Aralez Bio General Information
Description
Developer of noncanonical amino acids designed to make products in a sustainable way. The company has invented an enzymatic method for synthesizing noncanonical amino acids (NCAA) also called unusual or unnatural amino acids and the proprietary approach allows NCAA to be synthesized with enantiopurity in a single step, enabling clients to access amino acids that are needed for innovations in pharmaceuticals, agriculture, and functional materials.
Contact Information
Website
www.aralezbio.comCorporate Office
- 1933 Davis Street
- Suite 235
- San Leandro, CA 94577
- United States
Corporate Office
- 1933 Davis Street
- Suite 235
- San Leandro, CA 94577
- United States
Aralez Bio Timeline
Aralez Bio Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Later Stage VC (Series A) | 01-Dec-2024 | $10M | Completed | Generating Revenue | ||
3. Seed Round | 22-Aug-2022 | Completed | Generating Revenue | |||
2. Grant | 26-Jul-2019 | $25K | Completed | Startup | ||
1. Accelerator/Incubator | 12-Jun-2019 | Completed | Startup |
Aralez Bio Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | ||||||||
Seed 4 | ||||||||
Seed 3 | ||||||||
Seed 2 | 2,131,286 | $0.000100 | $0.94 | $0.94 | 1x | $0.94 | 6.71% | |
Seed 1 | 2,277,812 | $0.000100 | $0.51 | $0.51 | 1x | $0.51 | 7.18% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Aralez Bio Signals
Aralez Bio Investors (10)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Fifty Years | Venture Capital | Minority | ||
Spero Ventures | Venture Capital | Minority | ||
Astia | Venture Capital | Minority | ||
Climate Capital | Venture Capital | Minority | ||
Freeflow Ventures | Venture Capital | Minority |
Aralez Bio FAQs
-
When was Aralez Bio founded?
Aralez Bio was founded in 2019.
-
Where is Aralez Bio headquartered?
Aralez Bio is headquartered in San Leandro, CA.
-
What is the size of Aralez Bio?
Aralez Bio has 22 total employees.
-
What industry is Aralez Bio in?
Aralez Bio’s primary industry is Biotechnology.
-
Is Aralez Bio a private or public company?
Aralez Bio is a Private company.
-
What is the current valuation of Aralez Bio?
The current valuation of Aralez Bio is
. -
What is Aralez Bio’s current revenue?
The current revenue for Aralez Bio is
. -
How much funding has Aralez Bio raised over time?
Aralez Bio has raised $22M.
-
Who are Aralez Bio’s investors?
Fifty Years, Spero Ventures, Astia, Climate Capital, and Freeflow Ventures are 5 of 10 investors who have invested in Aralez Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »